Mon, February 11, 2013
Sun, February 10, 2013
Fri, February 8, 2013
Thu, February 7, 2013
Wed, February 6, 2013
Tue, February 5, 2013
Mon, February 4, 2013
Sun, February 3, 2013
Fri, February 1, 2013
[ Fri, Feb 01st 2013 ] - Market Wire
Director's Dealing

Andrew Peters Maintained (BIIB) at Strong Buy with Increased Target to $170 on, Feb 6th, 2013


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-170-on-feb-6th-2013.html
Published in Stocks and Investing on by   Print publication without navigation


Andrew Peters of Deutsche Bank, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $160 to $170 on, Feb 6th, 2013.

Andrew has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $166 on, Thursday, January 3rd, 2013
  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $141 on, Thursday, January 3rd, 2013
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Decreased Target to $139 on, Thursday, January 3rd, 2013


This is the rating of the analyst that currently disagrees with Andrew


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012